Skip to main content
Livermore
Livermore
ZHEN

Catalyst Capital Advisors LLC

SEC CIK
0001549275
Latest filing
Jul 24, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Catalyst Capital Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
82
Value
$40.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Catalyst Capital Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202682$40.7K<0.1%−25−23.4%ReducedHolders
Q1 2026107$47.8K<0.1%+9+9.2%AddedHolders
Q4 202598$44.4K<0.1%−26−21.0%ReducedHolders
Q3 2025124$48.6K<0.1%−33−21.0%ReducedHolders
Q2 2025157$69.9K<0.1%−45−22.3%ReducedHolders
Q1 2025202$97.9K<0.1%−9,343−97.9%ReducedHolders
Q4 20249,545$3.84M0.1%−225−2.3%ReducedHolders
Q3 20249,770$4.54M0.1%−325−3.2%ReducedHolders
Q2 202410,095$4.73M0.1%−48−0.5%ReducedHolders
Q1 202410,143$4.24M0.1%−174−1.7%ReducedHolders
Q4 202310,317$4.20M0.1%−798−7.2%ReducedHolders
Q3 202311,115$3.87M0.1%−327−2.9%ReducedHolders
Q2 202311,442$4.03M0.1%−605−5.0%ReducedHolders
Q1 202312,047$3.80M0.1%+1,022+9.3%AddedHolders
Q4 202211,025$3.18M0.1%+10,820+5,278.0%AddedHolders
Q3 2022205$59.0K<0.1%+2+1.0%AddedHolders
Q2 2022203$57.0K<0.1%+28+16.0%AddedHolders
Q1 2022175$46.0K<0.1%+31+21.5%AddedHolders
Q4 2021144$32.0K<0.1%−12−7.7%ReducedHolders
Q3 2021156$28.0K<0.1%−3−1.9%ReducedHolders
Q2 2021159$32.0K<0.1%+5+3.2%AddedHolders
Q1 2021154$33.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.